Bioprocess development of antibody-drug conjugate production for cancer treatment

Antibody-drug conjugate (ADC) is a class of targeted cancer therapies that combine the advantages of monoclonal antibody (mAb)’s specific targeting and chemotherapy’s potent cytotoxicity. The therapeutic effect of ADC is significantly affected by its bioproduction process. This study aims to develop...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Ou, Jianfa, Si, Yingnan, Goh, KahYong, Yasui, Norio, Guo, Yichen, Song, Jiajia, Wang, Lizhong, Jaskula-Sztul, Renata, Fan, Jinda, Zhou, Lufang, Liu, Runhua, Liu, Xiaoguang
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6198984/
https://ncbi.nlm.nih.gov/pubmed/30352095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206246
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares